Read the couple of recent posts by you and are suitably impressed. Keep them coming. Holding. P.S. The ANZ plot thickens (Opes prime) and is obviously going to have a bearing as to where this SP could be in six months time given an on market buy back could well be on the cards. I'd say their tax problem will be also resolved prior to the meeting date which is early NOV and with that obviously Ropren being sold. No point in selling it whilst tax implications are at hand and paying top tax dollars.
SLA Price at posting:
29.8¢ Sentiment: LT Buy Disclosure: Held